Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Bristol's $300 Mil. Settlement Leaves $170 Mil. In Reserve For Wholesaler Litigation

Jul 30 2004

• By Kate Rawson

Related Content

Bristol Re-Restates; Income Taxes, "Grants" May Be Ongoing Issues

Mar 15 2004

Bristol/ImClone's Erbitux Clears FDA; Undergoing Two Confirmatory Trials

Feb 12 2004

Bristol Takes $455 Mil. Litigation Charge, Higher Than Earlier Expectations

Jul 29 2004

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window